TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Click for best price
MARKET INSIGHTS
Global In-Line Softgels Drying System market size was valued at USD 16.8 million in 2024 and is projected to reach USD 39.9 million by 2032, exhibiting a CAGR of 13.5% during the forecast period. While the U.S. remains a key market, China is expected to show accelerated growth potential in the coming years.
In-Line Softgels Drying Systems are specialized pharmaceutical equipment designed to remove excess moisture from softgel capsules efficiently. These systems include technologies such as tumbler dryers and drying tunnels, which ensure uniform drying while maintaining capsule integrity. The process is critical for achieving optimal shelf stability and preventing microbial growth in sensitive formulations.
The market growth is driven by increasing pharmaceutical production, rising demand for nutraceuticals, and stricter regulatory requirements for product stability. Key players like Technophar (Mitsubishi Chemical Holdings Corporation) and SKY Softgel & Pack Co., Ltd. are expanding their manufacturing capabilities to meet growing demand. The health supplements segment, in particular, is witnessing rapid adoption of advanced drying technologies as consumer demand for high-quality softgel products continues to rise globally.
Robust Growth in the Global Nutraceutical and Pharmaceutical Industries to Propel Market Expansion
The In-Line Softgels Drying System market is experiencing significant growth, driven primarily by the expanding global nutraceutical and pharmaceutical sectors. The global nutraceuticals market, valued at over 400 billion dollars, is projected to grow at a compound annual growth rate of approximately 8 percent, creating immense demand for efficient softgel manufacturing equipment. In-Line Drying Systems are critical for reducing the residual moisture content in softgels to levels typically below 1 percent, which is essential for ensuring stability, shelf life, and preventing microbial growth. The pharmaceutical industry's stringent Good Manufacturing Practice (GMP) requirements further necessitate the adoption of automated, closed-loop drying systems that minimize human intervention and contamination risks. As pharmaceutical companies increasingly focus on high-potency active pharmaceutical ingredients (APIs) and innovative drug delivery systems, the precision and efficiency offered by advanced in-line dryers become indispensable.
Increasing Consumer Preference for Softgel Dosage Forms to Boost Market Growth
The growing consumer preference for softgel capsules over traditional tablets and powders is a major driver for the drying system market. Softgels offer superior bioavailability, ease of swallowing, and enhanced consumer appeal due to their smooth, sealed nature and ability to mask unpleasant tastes and odors. This has led to a surge in demand across various applications, including vitamins, omega-3 supplements, and prescription drugs. Consequently, manufacturers are scaling up production capacities, with some large-scale facilities requiring drying systems capable of handling outputs exceeding 500 kilograms per hour. The need for consistent, high-quality output at this scale directly fuels investments in advanced in-line drying technologies that can integrate seamlessly with gelation and sealing processes, reducing total processing time from several days to a matter of hours.
Furthermore, ongoing technological advancements focused on energy efficiency and process optimization are expected to sustain market momentum. Modern systems incorporate features like heat recovery and precise humidity control, which can reduce energy consumption by up to 30 percent compared to traditional batch drying tunnels.
➤ For instance, leading manufacturers are now integrating real-time moisture sensors and IoT-enabled controls that automatically adjust drying parameters, ensuring optimal results while minimizing operator dependency.
The convergence of these factors rising end-market demand, technological innovation, and the imperative for operational efficiency creates a strong foundation for continued market expansion.
MARKET CHALLENGES
High Initial Capital Investment and Operational Costs Pose Significant Challenges
Despite the promising growth trajectory, the high capital expenditure required for advanced In-Line Softgels Drying Systems presents a considerable challenge, particularly for small and medium-sized enterprises (SMEs). A single, fully automated in-line drying tunnel or tumbler system can represent an investment ranging from several hundred thousand to over a million dollars, depending on the capacity and level of automation. This substantial upfront cost includes not only the equipment itself but also the necessary infrastructure upgrades, installation, and validation processes to meet regulatory standards. For companies operating with thin margins or in developing regions, this financial barrier can delay or prevent the adoption of modern drying technologies, forcing them to rely on less efficient, labor-intensive batch drying methods that can compromise product quality and scalability.
Other Challenges
Complex Integration with Existing Production Lines
Integrating a new in-line drying system into an established softgel manufacturing line is a complex and disruptive process. It often requires significant downtime for installation, calibration, and synchronization with upstream gelation and downstream packaging equipment. This integration challenge is compounded by the need to ensure compatibility with various shell formulations, such as those based on gelatin or non-animal polymers like pullulan, which have different drying characteristics. A misstep during integration can lead to production bottlenecks, increased waste, and potential failures in quality assurance, making companies cautious about upgrading their equipment.
Stringent and Evolving Regulatory Compliance
Manufacturers must navigate a complex web of global regulatory standards, including those set by the FDA, EMA, and other national health authorities. These regulations govern every aspect of pharmaceutical manufacturing, from equipment design and material contact surfaces to the validation of drying processes and the resulting product quality data. Any change in regulatory requirements can necessitate costly modifications to existing systems or even render them non-compliant. The ongoing trend towards more rigorous data integrity and traceability requirements adds another layer of complexity, demanding sophisticated control systems and detailed documentation, which increases the operational burden.
Technical Limitations in Handling Diverse Formulations to Restrain Market Penetration
While in-line drying systems offer efficiency, they face technical restraints related to the handling of specialized and complex softgel formulations. The drying kinetics are highly dependent on the gel matrix composition, the nature of the fill material, and the desired final moisture content. For instance, softgels containing hydrophilic fills or those with delicate, heat-sensitive APIs require extremely precise control over temperature and air-flow profiles to prevent case hardening, where the outer shell dries too quickly and traps moisture inside, or API degradation. Standardized drying systems may struggle to achieve the required consistency across such a diverse product portfolio, leading to batch failures and quality deviations. This limitation can deter manufacturers of specialized pharmaceuticals from fully adopting in-line technology, preferring instead the slower but more controllable batch processes.
Additionally, the mechanical action in certain dryer types, like tumbler dryers, can be a concern for fragile softgels or those with intricate shapes, potentially causing abrasion, deformation, or rupture if not meticulously calibrated. The industry's shift towards plant-based and modified shell materials, which have different physical properties than traditional gelatin, further complicates the drying process and requires customized engineering solutions that are not always readily available.
Expansion into Emerging Markets and Contract Manufacturing to Unlock New Growth Avenues
The rapid expansion of the pharmaceutical and nutraceutical industries in emerging economies, particularly in the Asia-Pacific region, presents a substantial growth opportunity. Countries like China and India are not only large consumer markets but are also becoming global hubs for contract manufacturing. This regional market is expected to witness a growth rate significantly higher than the global average, driven by rising health awareness, disposable incomes, and government initiatives to strengthen local manufacturing capabilities. This creates a fertile ground for suppliers of In-Line Softgels Drying Systems, as new production facilities are established and existing manufacturers modernize their operations to meet international quality standards and export demands.
The growing trend of outsourcing softgel manufacturing to specialized Contract Development and Manufacturing Organizations (CDMOs) represents another key opportunity. CDMOs are continuously investing in state-of-the-art equipment to offer scalable, flexible, and efficient production services to their clients. They are often early adopters of advanced technologies like continuous manufacturing lines, where in-line drying is a critical component. Partnerships between drying system manufacturers and these CDMOs for developing customized, high-throughput solutions can lead to long-term recurring revenue streams and technological co-development.
Furthermore, the ongoing innovation in dryer technology, such as the development of systems that use alternative energy sources like infrared or microwave-assisted drying, opens up possibilities for radically reducing drying times and improving energy efficiency. Early adoption of these next-generation systems could provide a significant competitive edge to equipment manufacturers and their clients alike.
Tumbler Dryer Segment Leads the Market Due to Superior Efficiency in Batch Processing
The market is segmented based on type into:
Tumbler Dryer
Drying Tunnels
Others
Pharmaceutical Segment Dominates the Market Driven by High-Quality Sterilization Standards
The market is segmented based on application into:
Pharmaceutical
Health Supplements
Others
Automated Systems Gain Traction for Enhanced Process Control and Reduced Labor Costs
The market is segmented based on technology into:
Fully Automated Systems
Semi-Automated Systems
Manual Systems
High-Capacity Systems are in Demand to Cater to Large-Scale Manufacturing Needs
The market is segmented based on capacity into:
Small Scale (Less than 100 kg/batch)
Medium Scale (100-500 kg/batch)
Large Scale (More than 500 kg/batch)
Manufacturers Focus on Automation and Efficiency to Gain Competitive Edge
The competitive landscape of the global In-Line Softgels Drying System market is fragmented, characterized by a mix of established international corporations and specialized regional manufacturers. This structure is largely because the technology is a critical, specialized component within the broader pharmaceutical and nutraceutical manufacturing equipment ecosystem. Market players compete intensely on technological innovation, drying efficiency, automation levels, compliance with stringent Good Manufacturing Practices (GMP), and after-sales service support.
Technophar, a subsidiary of Mitsubishi Chemical Holdings Corporation, is widely recognized as a leading global player. Its dominance is attributed to a comprehensive portfolio of softgel encapsulation solutions, which includes highly advanced, automated in-line drying systems. The company's strong global sales and service network provides a significant advantage, enabling it to serve major pharmaceutical clients across North America, Europe, and Asia. Their systems are known for integrating seamlessly with encapsulation machines, ensuring a continuous manufacturing process that minimizes handling and contamination risks.
Similarly, SKY Softgel & Pack Co., Ltd. and GIC Engineering have carved out significant market shares by offering cost-effective and reliable drying solutions. These companies have particularly strong footholds in the Asian market, where the demand for health supplements is experiencing rapid growth. Their growth strategy often involves offering tailored solutions that meet the specific throughput and budgetary requirements of small to medium-sized enterprises in the nutraceutical sector. Meanwhile, companies like Biotec Solutions Ltd and Zhejiang Tianrui Pharmaceutical Machinery Co., Ltd compete by focusing on robust engineering and competitive pricing, making them popular choices in emerging markets.
Furthermore, the competitive dynamics are increasingly shaped by technological advancements. Manufacturers are investing heavily in Research and Development to introduce features like energy-efficient drying technologies, precise humidity and temperature controls, and Industry 4.0 integration for real-time monitoring and data analytics. These innovations are crucial as end-users demand higher productivity, consistent softgel quality, and reduced operational costs. Strategic initiatives such as partnerships with pharmaceutical companies for co-developing custom drying solutions and expansion into high-growth regions are common tactics employed to capture a larger market share.
The market also sees competition from manufacturers of complementary equipment, as seamless integration between the encapsulation, drying, and packaging lines is a key purchasing criterion. Therefore, companies that can offer a complete, integrated production line often hold a competitive advantage. As the market is projected to grow at a significant CAGR of 13.5%, this competition is expected to intensify, driving further innovation and consolidation in the coming years.
Technophar (Mitsubishi Chemical Holdings Corporation) (Canada)
SKY Softgel & Pack Co., Ltd. (South Korea)
GIC Engineering (India)
Wuxi Jangli Machinery Co.,Ltd (China)
Biotec Solutions Ltd (UK)
Zhejiang Tianrui Pharmaceutical Machinery Co., Ltd (China)
The integration of automation and Industry 4.0 principles is fundamentally reshaping the in-line softgels drying system landscape. Modern systems increasingly feature sophisticated Programmable Logic Controllers (PLCs) and Human-Machine Interfaces (HMIs) that allow for real-time monitoring and precise control over critical drying parameters such as temperature, humidity, and airflow. This shift towards smart, connected equipment enables predictive maintenance, reducing unplanned downtime and optimizing production efficiency. The demand for these advanced systems is primarily driven by the pharmaceutical industry's stringent regulatory requirements, where maintaining product consistency and ensuring data integrity are non-negotiable. Consequently, manufacturers are investing in technologies that offer higher levels of control and traceability, which is a significant factor contributing to the market's projected growth at a CAGR of 13.5%.
Sustainability and Energy Efficiency
Growing emphasis on sustainability is prompting a notable trend towards the development of more energy-efficient drying systems. Traditional drying processes are often energy-intensive, accounting for a substantial portion of a manufacturing plant's utility costs. However, recent advancements focus on optimizing heat recovery and utilizing advanced insulation materials to minimize thermal losses. Furthermore, some systems are now incorporating low-energy dehumidification technologies that significantly reduce overall power consumption. This focus on "greener" operations is not only driven by environmental regulations and corporate responsibility goals but also by the compelling economic incentive to lower operational expenditures, making energy-efficient systems an increasingly attractive investment for cost-conscious manufacturers.
The robust growth of the global nutraceutical and pharmaceutical industries is a primary driver for the in-line softgels drying system market. The rising consumer awareness of preventive healthcare has led to a surge in demand for dietary supplements, with the global nutraceuticals market valued in the hundreds of billions of dollars. Softgels are a preferred delivery format due to their precise dosing, ease of swallowing, and ability to mask unpleasant tastes. In the pharmaceutical sector, the development of complex formulations, including liposomal and self-emulsifying drug delivery systems, often requires the encapsulation and precise drying capabilities that in-line systems provide. This expansion across end-user industries underpins the market's growth from its 2024 valuation of $16.8 million towards the projected $39.9 million by 2032.
North America
The North American market for In-Line Softgels Drying Systems is characterized by a mature pharmaceutical sector and a significantly large health supplements industry. This drives consistent demand for high-throughput, precision drying equipment. The presence of stringent regulatory oversight from bodies like the U.S. Food and Drug Administration (FDA) mandates compliance with Current Good Manufacturing Practices (cGMP), making automation, data integrity, and process validation critical purchasing factors. Consequently, manufacturers in this region primarily invest in advanced systems like automated drying tunnels that offer precise control over temperature, humidity, and air flow to ensure batch consistency and product quality. While the initial capital expenditure is high, the focus is on long-term operational efficiency, reduced labor costs, and minimizing the risk of product loss. Furthermore, the growing consumer demand for nutraceuticals and personalized vitamins is prompting contract manufacturers and brand owners to upgrade their production lines, creating a steady replacement and modernization market for drying systems from established players.
Europe
Similar to North America, the European market is heavily influenced by a robust regulatory framework, including the European Medicines Agency (EMA) regulations and strict pharmacopoeial standards. This environment prioritizes equipment that ensures product safety and traceability. European pharmaceutical manufacturers are known for their emphasis on sustainability and energy efficiency, leading to a preference for drying systems that minimize energy consumption and incorporate heat recovery mechanisms. The market is also seeing a trend towards modular and flexible systems that can handle smaller, more specialized batches, catering to the rise in personalized medicine and clinical trial manufacturing. Collaboration between machine manufacturers and pharmaceutical companies is common, focusing on co-developing solutions that integrate seamlessly with other upstream and downstream processes. While the market is well-established, growth is sustained by continuous technological upgrades and the region's strong export-oriented pharmaceutical industry, which demands world-class manufacturing capabilities.
Asia-Pacific
The Asia-Pacific region is the fastest-growing and largest volume market for In-Line Softgels Drying Systems, driven predominantly by the expanding pharmaceutical and nutraceutical industries in China and India. This growth is fueled by rising disposable incomes, increasing health awareness, and government initiatives to improve healthcare infrastructure. The market here is highly diverse, with demand spanning from cost-effective, semi-automated tumbler dryers favored by small to mid-sized enterprises to sophisticated, fully automated drying tunnels required by large multinational corporations and leading domestic manufacturers. While price sensitivity remains a key factor, there is a palpable and accelerating shift towards higher-quality, automated systems as manufacturers aim to improve efficiency, scale up production, and meet international quality standards for export markets. Local manufacturers of drying equipment are increasingly competitive, offering technologically advanced solutions at attractive price points, which intensifies competition for global players.
South America
The South American market for In-Line Softgels Drying Systems is emerging, with growth opportunities linked to the gradual modernization of the regional pharmaceutical sector. Countries like Brazil and Argentina represent the core of this market. However, growth is often tempered by economic volatility and fluctuating currency exchange rates, which can delay capital investment decisions by manufacturers. The market is characterized by a mix of older, manual drying equipment and newer, imported automated systems. Demand is primarily driven by the need to replace aging infrastructure to improve productivity and comply with evolving national regulatory standards. While there is interest in advanced technology, the procurement process is often lengthy and cautious, with a strong emphasis on the return on investment and after-sales service support. Suppliers who can offer robust, reliable equipment with strong local technical service networks are best positioned to succeed in this region.
Middle East & Africa
The market in the Middle East and Africa is in a nascent stage but holds long-term potential. Growth is primarily concentrated in more economically developed nations in the Gulf Cooperation Council (GCC), such as Saudi Arabia and the UAE, where governments are actively promoting local pharmaceutical manufacturing to reduce dependency on imports. This "pharmaceutical localization" drive is creating new demand for complete softgel manufacturing lines, including drying systems. The focus in these projects is often on acquiring modern, turnkey solutions that meet international standards. In contrast, across much of Africa, the market is constrained by limited local manufacturing capacity and a reliance on imported finished products. However, gradual improvements in healthcare access and economic development are expected to slowly fuel demand over the coming decade, albeit from a relatively small base. Success in this diverse region requires a highly tailored approach to address the specific needs and challenges of each country.
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
Target audience includes manufacturers, suppliers, distributors, investors, regulators, and policymakers
-> Key players include Technophar (Mitsubishi Chemical Holdings Corporation), SKY Softgel & Pack Co., Ltd., GIC Engineering, Wuxi Jangli Machinery Co.,Ltd, Biotec Solutions Ltd, and Zhejiang Tianrui Pharmaceutical Machinery Co., Ltd.
-> Key growth drivers include increasing global demand for pharmaceutical and nutraceutical softgels, the need for improved production efficiency, and stringent regulatory requirements for product quality and stability.
-> Asia-Pacific is the largest and fastest-growing market, driven by expanding pharmaceutical manufacturing capabilities, particularly in China and India.
-> Emerging trends include the integration of Industry 4.0 technologies for real-time monitoring, the development of energy-efficient drying systems, and a focus on continuous manufacturing processes to enhance productivity.
| Report Attributes | Report Details |
|---|---|
| Report Title | In-Line Softgels Drying System Market, Global Outlook and Forecast 2025-2032 |
| Historical Year | 2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year | 2024 |
| Forecast Year | 2032 |
| Number of Pages | 103 Pages |
| Customization Available | Yes, the report can be customized as per your need. |
Frequently Asked Questions
